01-06-2020 | Computed Tomography | Letter to the Editor
Comment on: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”
Published in: Targeted Oncology | Issue 3/2020
Login to get access